Gerasimos Mantzaris

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Inflammatory bowel disease: Greek patients' perspective on quality of life, information on the disease, work productivity and family support.

Nikos Viazis, Gerasimos Mantzaris, Konstantinos Κarmiris et al. · PubMed · 2013 · 24 citations

Medicine, Clinical Sciences, Psychology +11

Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort

Giorgos Bamias, Georgios Kokkotis, Michalis Gizis et al. · Digestive Diseases and Sciences · 2021 · 19 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Response to Anti-α4β7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline

Maria Gazouli, Nikolas Dovrolis, Marilena M. Bourdakou et al. · Inflammatory Bowel Diseases · 2021 · 15 citations

Life Sciences, Immunology, Molecular Biology +17

Lamivudine treatment for acute severe hepatitis B: report of a case and review of the literature.

Anastassios Roussos, Stavroula Koilakou, I. Kalafatas et al. · PubMed · 2008 · 12 citations

Pharmacy, Pharmacology, Pharmacotherapy +17